PDA

Company Overview
Company Details
Case Studies
Hulio wins PDA award for device innovation.
PDA’s First Drug Delivery Innovation Award Winners at 2019 Universe of Pre-Filled Syringes and Injection Devices Conference
Nov 4th, 2019
Visible Particulate FDA Recall Notices by year as compiled by John Shabushnig, Insight Pharma Consulting, from FDA data. Reprinted with permission.
Particles in Parenterals: 2019 Update
Oct 4th, 2019
How can you “measure” the culture at your organization, or that of potential partner? PDA developed a tool to evaluate quality culture and a case study for training, built on the premise of a firm evaluating a potential CMO.
PDA Quality Culture Assessment
Jun 22nd, 2018
Company News
PDA Container Closure Performance and Integrity Conference in June
PDA Container Closure Performance and Integrity Conference in June
May 7th, 2018
Empowering employees with a strong sense of ownership can lead to improved outcomes and increased cost efficiency.
Live from PDA/FDA: Culture of Quality
Sep 12th, 2017
Glass is inherently strong and an appropriate choice for parenteral drug packaging, but it is vulnerable to surface damage.
PDA Developing Glass Handling Technical Report
Jun 26th, 2017
Hal Baseman, Chief Operations Officer at ValSource, LLC and Richard Johnson, President & CEO of PDA at the 2017 PDA Annual Meeting
PDA Becomes an ANSI Accredited Standards Developer
Apr 4th, 2017
The EMVO’s Centralized Approach to Meeting the Falsified Medicines Directive
Oct 20th, 2016
More from PDA
Hulio wins PDA award for device innovation.
PDA’s First Drug Delivery Innovation Award Winners at 2019 Universe of Pre-Filled Syringes and Injection Devices Conference
One award winner includes a thinner needle to reduce injection pain, while a partnership resulted in a precise microliter dosing syringe.
Nov 4th, 2019
Visible Particulate FDA Recall Notices by year as compiled by John Shabushnig, Insight Pharma Consulting, from FDA data. Reprinted with permission.
Particles in Parenterals: 2019 Update
FDA expects a visual inspection program and parenteral manufacturers should expect questions about their program during any inspection. What's new in 2019?
Oct 4th, 2019
How can you “measure” the culture at your organization, or that of potential partner? PDA developed a tool to evaluate quality culture and a case study for training, built on the premise of a firm evaluating a potential CMO.
PDA Quality Culture Assessment
How can you “measure” the culture at your organization, or that of potential partner? PDA developed a tool to evaluate quality culture and a case study for training, built on the premise of a firm evaluating a potential CMO.
Jun 22nd, 2018
PDA Container Closure Performance and Integrity Conference in June
PDA Container Closure Performance and Integrity Conference in June
At the event in Bethesda, MD, exchange ideas with industry peers and regulatory experts on meeting packaging demands for new medicines, novel delivery devices, and evolving regulations.
May 7th, 2018
Els Poff, Executive Director of the Data Integrity Center of Excellence at Merck
Data Integrity Code of Conduct
While the FDA asks pharma companies to heed its warnings around good manufacturing practices, the Parenteral Drug Association outlines actions to take.
Apr 27th, 2018
Managing the risks of temperature excursions is of vital importance for many life sciences products.
Managing the Risks of Temperature Excursions
Baxter’s voluntary recall serves as a reminder of the importance of managing life science product temperatures through the supply chain.
Oct 6th, 2017
Empowering employees with a strong sense of ownership can lead to improved outcomes and increased cost efficiency.
Live from PDA/FDA: Culture of Quality
Empowering employees with a strong sense of ownership can lead to improved outcomes and increased cost efficiency.
Sep 12th, 2017
Temperature-Sensitive Packaging and Distribution for Biopharmaceuticals
Cold Chain Technologies and the Parenteral Drug Assn. announce Oct. 25-26 course to better achieve an effective cold chain.
Jul 17th, 2017
Glass is inherently strong and an appropriate choice for parenteral drug packaging, but it is vulnerable to surface damage.
PDA Developing Glass Handling Technical Report
Glass is inherently strong and an appropriate choice for parenteral drug packaging, but it is vulnerable to surface damage. PDA is underway developing a technical report focused on best practices and methods for evaluating glass handling methods.
Jun 26th, 2017